Cardiac Arrest clinical trials at UCSD
2 in progress, 1 open to eligible people
RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
open to eligible people ages 18 years and up
This Phase 1 dose escalation trial will assess the safety and preliminary efficacy of a single dose intravenous infusion of RP-A601 in high-risk adult patients with PKP2-ACM.
La Jolla, California and other locations
Functional Substrate-Only Guided VT Ablation
Sorry, accepting new patients by invitation only
Ventricular tachycardia (VT) is a leading cause of death and suffering in the Veteran population. Currently, ablation procedures are performed to destroy the diseased tissue that causes this problem. This study will test to see if an experimental strategy of only targeting regions of slow conduction without the induction of VT can improve the efficacy and safety of VT ablation. Once this study is completed, the investigators will know whether this ablation strategy could help increase the efficacy, safety and efficiency of ablation therapy of fatal heart rhythms.
San Diego, California
Our lead scientists for Cardiac Arrest research studies include Gordon Ho, MD Barry Greenberg, MD.